Stay updated on Secured Access to Nivolumab for Rare Cancers Clinical Trial
Sign up to get notified when there's something new on the Secured Access to Nivolumab for Rare Cancers Clinical Trial page.
Latest updates to the Secured Access to Nivolumab for Rare Cancers Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedRevision: v3.4.2 was added to the site; the prior lapse-in-funding notice and Revision: v3.4.1 were removed, and to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%
- Check21 days agoChange DetectedAdded a site-wide notice about a lapse in government funding. Updated the revision to v3.4.1, replacing the previous v3.4.0 tag.SummaryDifference0.4%
- Check28 days agoChange DetectedAdditions: Show glossary, Last Update Submitted that Met QC Criteria, No FEAR Act Data, and Revision: v3.4.0. Deletions: Last Update Submitted that met QC Criteria, No FEAR Act data, Revision: v3.3.4.SummaryDifference0.2%
- Check42 days agoChange DetectedThe update adds a minor revision notice: Revision: v3.3.4 appears and Revision: v3.3.3 is removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%
- Check64 days agoChange DetectedAdded the label 'Revision: v3.3.3' to the page and removed the 'HHS Vulnerability Disclosure' link along with the previous 'Revision: v3.3.2' entry.SummaryDifference0.1%
- Check85 days agoChange DetectedThe page displays Revision: v3.3.2, replacing the previous v3.3.1. No study content or functionality is affected by this update.SummaryDifference0.1%
Stay in the know with updates to Secured Access to Nivolumab for Rare Cancers Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Secured Access to Nivolumab for Rare Cancers Clinical Trial page.